Abiopharma

New Form SCHEDULE 13D/A - Vor Biopharma Inc. Filed: 2025-10-27 AccNo: 0001346824-25-000029 Size: 19 KB

Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA

RA CAPITAL MANAGEMENT, L.P. 🔴 sold 221.2K shares of Vor Biopharma Inc. (VOR) at $28.12 ($6.2M) Transaction Date: Oct 23, 2025 | Filing ID: 000359

Accardi Mario Alberto 🟡 adjusted position in 8.0K shares (1 derivative) of Centessa Pharmaceuticals plc (CNTA) at $25.00 Transaction Date: Oct 27, 2025 | Filing ID: 000273

Telman Deborah H 🟡 adjusted position in 241 shares (1 derivative) of GILEAD SCIENCES, INC. (GILD) at $120.94 Transaction Date: Oct 25, 2025 | Filing ID: 000007

Bassan Abraham 🟢 acquired 100.0K shares (1 derivative) of Rani Therapeutics Holdings, Inc. (RANI) at $2.09 Transaction Date: Oct 23, 2025 | Filing ID: 000005

New Form 3 - Rani Therapeutics Holdings, Inc. Filed: 2025-10-27 AccNo: 0001864485-25-000003 Size: 9 KB

IMRAN MIR A 🟢 acquired 4.2M shares (1 derivative) of Rani Therapeutics Holdings, Inc. (RANI) at $0.60 ($2.3M) Transaction Date: Oct 23, 2025 | Filing ID: 000004

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

Director Craig Adam R 🟢 acquired 86.2K shares of X4 Pharmaceuticals, Inc (XFOR) at $2.90 Transaction Date: Oct 23, 2025 | Filing ID: 000035

New Form 3 - BIOVIE INC. Filed: 2025-10-27 AccNo: 0001520138-25-000326 Size: 8 KB

Bizily Scott 🟡 adjusted position in 2.7K shares (1 derivative) of 4D Molecular Therapeutics, Inc. (FDMT) at $12.00 Transaction Date: Oct 24, 2025 | Filing ID: 251874

New Form 3 - Longeveron Inc. Filed: 2025-10-27 AccNo: 0001214659-25-015388 Size: 7 KB

Paletta George A. Jr. 🟢 acquired 34.0K shares of Longeveron Inc. (LGVN) Transaction Date: Oct 01, 2025 | Filing ID: 015389

Director WIERENGA WENDELL 🟡 adjusted position in 4.4K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $58.68 Transaction Date: Oct 27, 2025 | Filing ID: 000026